vs

Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $42.3M, roughly 1.4× WIDEPOINT CORP). WIDEPOINT CORP runs the higher net margin — -2.0% vs -83.0%, a 81.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 12.3%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 11.2%).

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...

RYTM vs WYY — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.4× larger
RYTM
$57.3M
$42.3M
WYY
Growing faster (revenue YoY)
RYTM
RYTM
+24.6% gap
RYTM
36.9%
12.3%
WYY
Higher net margin
WYY
WYY
81.0% more per $
WYY
-2.0%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
11.2%
WYY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RYTM
RYTM
WYY
WYY
Revenue
$57.3M
$42.3M
Net Profit
$-47.5M
$-849.4K
Gross Margin
91.6%
13.8%
Operating Margin
-82.2%
-1.9%
Net Margin
-83.0%
-2.0%
Revenue YoY
36.9%
12.3%
Net Profit YoY
-9.6%
-138.3%
EPS (diluted)
$-0.73
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RYTM
RYTM
WYY
WYY
Q4 25
$57.3M
$42.3M
Q3 25
$51.3M
$36.1M
Q2 25
$48.5M
$37.9M
Q1 25
$32.7M
$34.2M
Q4 24
$41.8M
$37.7M
Q3 24
$33.3M
$34.6M
Q2 24
$29.1M
$36.0M
Q1 24
$26.0M
$34.2M
Net Profit
RYTM
RYTM
WYY
WYY
Q4 25
$-47.5M
$-849.4K
Q3 25
$-52.9M
$-559.2K
Q2 25
$-46.6M
$-618.5K
Q1 25
$-49.5M
$-724.1K
Q4 24
$-43.3M
$-356.4K
Q3 24
$-43.6M
$-425.2K
Q2 24
$-32.3M
$-499.6K
Q1 24
$-141.4M
$-653.1K
Gross Margin
RYTM
RYTM
WYY
WYY
Q4 25
91.6%
13.8%
Q3 25
89.3%
14.6%
Q2 25
88.6%
13.5%
Q1 25
88.8%
14.0%
Q4 24
90.9%
12.6%
Q3 24
88.5%
13.6%
Q2 24
89.9%
13.6%
Q1 24
89.2%
13.6%
Operating Margin
RYTM
RYTM
WYY
WYY
Q4 25
-82.2%
-1.9%
Q3 25
-102.6%
-1.3%
Q2 25
-93.4%
-1.9%
Q1 25
-143.7%
-2.4%
Q4 24
-98.6%
-0.8%
Q3 24
-132.0%
-1.3%
Q2 24
-139.2%
-1.3%
Q1 24
-538.7%
-1.9%
Net Margin
RYTM
RYTM
WYY
WYY
Q4 25
-83.0%
-2.0%
Q3 25
-103.1%
-1.5%
Q2 25
-96.1%
-1.6%
Q1 25
-151.4%
-2.1%
Q4 24
-103.6%
-0.9%
Q3 24
-131.2%
-1.2%
Q2 24
-110.9%
-1.4%
Q1 24
-544.4%
-1.9%
EPS (diluted)
RYTM
RYTM
WYY
WYY
Q4 25
$-0.73
$-0.08
Q3 25
$-0.82
$-0.06
Q2 25
$-0.75
$-0.06
Q1 25
$-0.81
$-0.08
Q4 24
$-0.71
$-0.05
Q3 24
$-0.73
$-0.04
Q2 24
$-0.55
$-0.05
Q1 24
$-2.35
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RYTM
RYTM
WYY
WYY
Cash + ST InvestmentsLiquidity on hand
$388.9M
$9.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$139.1M
$11.5M
Total Assets
$480.2M
$79.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RYTM
RYTM
WYY
WYY
Q4 25
$388.9M
$9.8M
Q3 25
$416.1M
$12.1M
Q2 25
$291.0M
$6.8M
Q1 25
$314.5M
$3.7M
Q4 24
$320.6M
$6.8M
Q3 24
$298.4M
Q2 24
$319.1M
Q1 24
$201.2M
Stockholders' Equity
RYTM
RYTM
WYY
WYY
Q4 25
$139.1M
$11.5M
Q3 25
$148.8M
$12.2M
Q2 25
$-11.9M
$12.6M
Q1 25
$18.9M
$13.0M
Q4 24
$21.7M
$13.6M
Q3 24
$11.2M
$13.8M
Q2 24
$39.3M
$14.0M
Q1 24
$61.6M
$14.2M
Total Assets
RYTM
RYTM
WYY
WYY
Q4 25
$480.2M
$79.8M
Q3 25
$506.9M
$70.6M
Q2 25
$372.7M
$76.6M
Q1 25
$386.7M
$71.4M
Q4 24
$392.3M
$71.6M
Q3 24
$363.6M
$56.9M
Q2 24
$381.8M
$58.6M
Q1 24
$258.7M
$54.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RYTM
RYTM
WYY
WYY
Operating Cash FlowLast quarter
$-25.4M
$-173.5K
Free Cash FlowOCF − Capex
$-270.0K
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RYTM
RYTM
WYY
WYY
Q4 25
$-25.4M
$-173.5K
Q3 25
$-26.6M
$5.9M
Q2 25
$-23.3M
$3.2M
Q1 25
$-40.4M
$-3.2M
Q4 24
$-18.8M
$2.4M
Q3 24
$-25.2M
$1.9M
Q2 24
$-29.1M
$-1.1M
Q1 24
$-40.7M
$-1.6M
Free Cash Flow
RYTM
RYTM
WYY
WYY
Q4 25
$-270.0K
Q3 25
$5.9M
Q2 25
$3.1M
Q1 25
$-3.3M
Q4 24
$2.4M
Q3 24
$1.8M
Q2 24
$-1.1M
Q1 24
$-1.6M
FCF Margin
RYTM
RYTM
WYY
WYY
Q4 25
-0.6%
Q3 25
16.4%
Q2 25
8.1%
Q1 25
-9.5%
Q4 24
6.4%
Q3 24
5.3%
Q2 24
-3.0%
Q1 24
-4.6%
Capex Intensity
RYTM
RYTM
WYY
WYY
Q4 25
0.2%
Q3 25
0.1%
Q2 25
0.2%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RYTM
RYTM

Segment breakdown not available.

WYY
WYY

Carrier Services$26.8M63%
Managed Services$15.5M37%

Related Comparisons